Prostate cancer often progresses without a single warning sign, making early detection a matter of vigilance rather than a response to symptoms. For Stuart Rainey, a man from Lisburn, a diagnosis at age 46—arriving on his birthday in 2020—underscored the critical importance of knowing one’s family history and the role of proactive screening in preventing the spread of the disease.
A diagnosis without symptoms
Stuart’s experience highlights a common and challenging aspect of prostate cancer: the absence of early indicators. While some men may experience difficulty urinating or notice blood in their urine or semen, many others feel entirely healthy. Stuart had experienced no such symptoms, though he did notice some pain in his hip.
Aware of a family history of prostate cancer, Stuart sought a Prostate-Specific Antigen (PSA) test from his GP. This decision initiated a diagnostic sequence—elevated PSA levels followed by an MRI and a biopsy—that confirmed the cancer. The news was devastating, particularly with two children, then aged 10 and 12, but the early detection proved decisive. Since the cancer had not yet spread, Stuart was able to choose treatment and undergo the removal of his prostate.
Six years after his diagnosis, Stuart has received a “five year, all clear.” He describes himself as healthy and fit, returning to active family life, including hiking in the Mournes and planning wild camping trips with his son.
Stuart’s recovery was supported by the medical team at Ulster Hospital, including Urology Specialist Nurse Pamela Neill and Advanced Nurse Practitioner Claire Cassells, whose guidance helped manage the anxiety and uncertainty that often accompany a cancer diagnosis.
The prevalence and risk in the UK
Prostate cancer is the most common cancer among men in the UK. Statistics indicate that more than 64,000 men are diagnosed every year, and approximately one in eight men will be affected by the disease during their lifetime.
Medical professionals advise that men over 50, or those with a family history of the disease, should speak with their GP about their specific risk. While the PSA test is a primary tool for early detection, We see not a definitive diagnostic for cancer on its own. it serves as a signal that further investigation, such as imaging or biopsies, may be necessary.
Clinical Note: Understanding PSA Fluctuations
A PSA (Prostate-Specific Antigen) test measures a protein produced by the prostate. While elevated levels can indicate cancer, they can also be raised by non-cancerous factors. Recent ejaculation, urinary tract infections, or vigorous cycling can temporarily increase PSA levels. Patients are encouraged to discuss the timing of their test with their GP to ensure the most accurate reading.
The goal of early detection is to identify the cancer before it spreads, which significantly simplifies treatment options and improves long-term outcomes. As Stuart emphasizes, there is no reason for embarrassment when seeking these checks; the risks of avoiding the doctor far outweigh the discomfort of the appointment.
When to seek medical advice
While asymptomatic cases are common, certain “red flags” should prompt an immediate GP visit:
- Persistent pelvic or back pain
- Noticeable changes in urinary function
- Blood in the urine or semen
For those without symptoms, the decision to screen is often based on age, and genetics. Speaking with a healthcare provider allows for a personalized risk assessment that can potentially save a life.
Common Questions on Early Detection
Is a PSA test enough to diagnose cancer?
No. A PSA test can detect prostate problems early, but it is not definitive. If levels are elevated, doctors typically use MRIs and biopsies to confirm whether cancer is present.
At what age should I start discussing risk with my doctor?
General guidance suggests men over 50 should speak to their GP, though those with a family history may need to do so much earlier, as seen in Stuart’s case at age 46.
How often do you discuss preventative health screenings with your primary care provider?
